Navigation Links
NewGen Therapeutics Presents Data on NT-113, A Novel Pan-ErbB Inhibitor, at American Association of Cancer Research
Date:4/8/2013

1 brain/plasma concentrations)
  • Excellent oral bioavailability and pharmacokinetics
  • Potency against the distinct EGFR mutations found in both GBM and other solid tumors including extra-cranial malignancies such as NSCLC, breast cancer and melanoma
  • Demonstrated potent anti-cancer activity in an HER2 positive gastric cancer, T790M mutant NSCLC and GBM39 intracranial mouse xenograft studies
  • "These unique differentiating attributes have the potential to make NT-113 the preferred treatment for patients with malignancies that over-express members of the ErbB family, including GBM, NSCLC, breast cancer, gastric cancer, colon cancer, head and neck cancer, and melanoma," commented Harry D. Pedersen , President and Chief Executive Officer. "Over 90% of solid tumors over-express at least one ErbB receptor. Agents targeting single receptors in the family, including Iressa®, Herceptin®, Erbitux® and Tarceva®, have made a significant impact on survival in a number of cancers and account for billions of dollars in annual sales.  A single agent that targets all receptors in the family should result in better overall clinical outcomes."

    "Moreover, NT-113's remarkable ability to cross the blood brain barrier suggests it could be particularly beneficial to patients with GBM or brain metastases from susceptible primary cancer types. While current agents that target individual ErbB receptors have high clinical response rates and significant increases in survival, patients frequently progress with brain metastases.  Since no other currently approved ErbB inhibitors cross the blood brain barrier, NT-113 has the potential to be a major advancement in the treatment of cancers that over-express one of the ErbB receptors and tend to metastasis to the brain.  Our plan is to initially focus on GBM, where EGFR is a validated target and we have a chance for an accelerated approval wi
    '/>"/>

    SOURCE NewGen Therapeutics
    Copyright©2012 PR Newswire.
    All rights reserved

    Page: 1 2 3

    Related medicine technology :

    1. Cell Therapeutics, Inc. (CTI) to Report First Quarter Financial Results on April 20
    2. Faruqi & Faruqi, LLP Encourages Investors Who Suffered Substantial Losses Investing in Chelsea Therapeutics International, Ltd. to Contact the Firm
    3. Argos Therapeutics Secures $25 million Series D Financing to Commence Phase 3 ADAPT Study in Patients with Metastatic Renal Cell Carcinoma (mRCC) in Mid-2012
    4. Novelos Therapeutics Announces Successful Completion of First Cohort In Lung Cancer Trial With I-124-CLR1404 (LIGHT) Cancer-Targeted PET Imaging Agent at UW Carbone Cancer Center
    5. Zacks Industry Outlook Highlights: Eli Lilly, Forest Labs, ViroPharma, Novartis and United Therapeutics
    6. Oxford BioTherapeutics Appoints Senior Industry Leader to Head its New Clinical Development Operations in Basel, Switzerland
    7. Nektar Therapeutics Reports Financial Results for the First Quarter of 2012
    8. Cara Therapeutics Licenses Novel Kappa Opioid Agonist, CR845, to Chong Kun Dang Pharmaceutical Corporation For South Korean Market
    9. Frost & Sullivan: High Uptake of New Drug Therapies and Aging Population Expansion Keep the U.S. Retinal Therapeutics Market Buoyant
    10. Zenobia Therapeutics, Inc. And BioBlocks, Inc. Announce Sale Of A Joint Fragment Library Ideal For Screening By All Popular Methods
    11. New Forecast Shows Global Protein Therapeutics Market to Reach $143.4 Billion by 2015
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:10/30/2014)... , Oct. 30, 2014 /CNW/ - Atlantic Canadians ... agreement reached between Canada,s provinces ... Keon , President of the Canadian Generic Pharmaceutical Association ... the comments while speaking at the Atlantic Summit on ... , which is being hosted by the Public ...
    (Date:10/30/2014)... -- WuXi PharmaTech (Cayman) Inc. (NYSE: WX ), ... serving the pharmaceutical, biotechnology, and medical device industries, with ... the United States , today announced the ... Tel Aviv area of Israel.  ... of integrated R&D services to local customers. It will ...
    (Date:10/30/2014)... 30, 2014   ViaDerma, Inc. (OTCQB: ... new products to market, has recently released a ... is a topical liquid tetracycline-based antibiotic that uses ... convert oral medication active ingredients into topical drugs. ... aid antibiotic to help prevent skin infection in ...
    Breaking Medicine Technology:Atlantic Canadians to Save $560-Million Through Unprecedented Three-Year Pan-Canadian Agreement on Generic Prescription Medicines 2Atlantic Canadians to Save $560-Million Through Unprecedented Three-Year Pan-Canadian Agreement on Generic Prescription Medicines 3WuXi AppTec Launches Representative Office in Israel, Forms Strategic Collaboration with Pontifax 2ViaDerma, Inc. Lead Product TetraStem Shown Effective in Fighting Staph Infections including MRSA 2ViaDerma, Inc. Lead Product TetraStem Shown Effective in Fighting Staph Infections including MRSA 3
    (Date:10/31/2014)... (PRWEB) October 31, 2014 The Suspension ... this workout program was developed by Dan Long, a ... well-known as a fitness professional and life coach. The ... and having toned muscles is not impossible , The ... on suspension training. Suspension training promises efficiency when it ...
    (Date:10/31/2014)... October 31, 2014 Urban Hydroponics, Inc. ... today announced it has signed a Binding Letter of ... the urban cultivation sector - Urban Cultivator Inc. (“Urban ... and W3 Metal Inc. (“W3 Metal” and together with ... Pursuant to the LOI and an earlier non-binding ...
    (Date:10/31/2014)... October 31, 2014 Florida Air ... and girls in grades 6-12, is taking the ... sports injuries and concussions, becoming the first high ... ImPACT (Immediate Post-Concussion Assessment and Cognitive Testing) computerized ... NFL Player' lawsuit grabs the headlines, and the ...
    (Date:10/31/2014)... NY (PRWEB) October 31, 2014 In an ... York patients, Dr. Majid Jamali announced he will soon offer ... practice by the end of November. , To build ... Maxillofacial Surgery of New York has become known for, Dr. ... boasts degrees from such top learning institutions as UCLA, Stanford ...
    (Date:10/31/2014)... 2014 Phoenix dentist , Dr. Christy, ... November. Whether patients simply need routine care or have a ... than now to get that necessary care. The right dental ... routine and even essential treatments due to financial concerns. Throughout ... on any treatments offered by the team at Christy Dental ...
    Breaking Medicine News(10 mins):Health News:Suspension Revolution Review Reveals Dan Long's New Suspension Workout Plan 2Health News:Urban Hydroponics Inc. Signs Definitive Agreement to Merge with Canadian Hydroponics Companies 2Health News:Urban Hydroponics Inc. Signs Definitive Agreement to Merge with Canadian Hydroponics Companies 3Health News:Urban Hydroponics Inc. Signs Definitive Agreement to Merge with Canadian Hydroponics Companies 4Health News:Urban Hydroponics Inc. Signs Definitive Agreement to Merge with Canadian Hydroponics Companies 5Health News:Florida Air Academy Tackling Concussions Head-On 2Health News:Florida Air Academy Tackling Concussions Head-On 3Health News:Oral & Maxillofacial Surgery of New York Adds Orthodontic Patient Services 2Health News:Oral & Maxillofacial Surgery of New York Adds Orthodontic Patient Services 3Health News:Phoenix Dentist, Dr. Christy, is Now Offering Ten Percent Off On All Dental Treatments for the Month of November 2
    ... and preschool-aged children may be a significant risk factor ... the September issue of Archives of Pediatrics & ... napping does not appear to be an adequate substitute ... "Obesity defined as having age- and sex-specific ...
    ... By Jenifer Goodwin HealthDay Reporter , MONDAY, Sept. ... at least if you,re bringing in about $75,000 a year, ... household incomes up to about $75,000, beyond that, earning more ... study. But that doesn,t mean you should give up ...
    ... 3 (HealthDay News) -- Scientists report that they may have ... early to know if the findings could lead to earlier ... diagnose autism in the second year of life or later, ... at Children,s Hospital of Philadelphia, explained in an interview. Earlier ...
    ... HealthDay Reporter , FRIDAY, Sept. 3 (HealthDay News) -- ... and high-end offices, bedbugs are popping up in droves although, ... just your bed. According to a National ... U.S. pest management companies surveyed said they had "encountered a ...
    ... (Geneva, Switzerland) Following the imprisonment of Maxim Popov in ... promotion of HIV prevention efforts in Uzbekistan, the International AIDS ... practitioner working in HIV prevention in Ukraine. Dr. Illya ... for people using drugs, was detained on 28 May 2010 ...
    ... , FRIDAY, September 3 (HealthDay News) -- A 7-year-old San Diego ... trip to Switzerland a couple years ago. While there, he ... to have him vaccinated against. Upon his return to the United ... story -- a true tale -- is the type of nightmare ...
    Cached Medicine News:Health News:Short nighttime sleep duration among infants, young children associated with obesity in later life 2Health News:After $75,000, Money Can't Buy Day-to-Day Happiness 2Health News:After $75,000, Money Can't Buy Day-to-Day Happiness 3Health News:Infants May Display Subtle Autism Signs at 6 Months: Study 2Health News:Bedbug Nation: Critters Make a Comeback 2Health News:Bedbug Nation: Critters Make a Comeback 3Health News:Bedbug Nation: Critters Make a Comeback 4Health News:IAS calls for an end to harassment, intimidation and imprisonment of HIV professionals 2Health News:IAS calls for an end to harassment, intimidation and imprisonment of HIV professionals 3Health News:Disease May Be Only a Plane Ride Away 2Health News:Disease May Be Only a Plane Ride Away 3
    The only ergonomic work station of its kind with an optional built-in keratograph and flat-screen. The Concepta is a modern workstation for the examination and refraction of patients....
    The natural look of 3 in 1 technology in virtually any prescription....
    Dot matrix pattern for light eyed patients....
    Natural eye color change for even the darkest of eyes....
    Medicine Products: